The FDA has issued a proposal to remove a common decongestant in over the counter products.

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.

One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...

HealthDay News — The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion.

Credit: Journey Medical Corporation. The approval was supported by data from 2 randomized, double-blind, active- and ...

Policies varied in the testing required, funding, processes after a positive screening result, and decision-making around concerning results. HealthDay News — Institutional leaders consider policies ...

Clear cell hidradenoma is a tumor that results from overgrowth of either eccrine or apocrine sweat glands. Lesions are most ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams.

Early-life exposure to nitrogen dioxide, fine particulate matter linked to prevalence and persistence of peanut allergy ...